These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9719205)

  • 1. Behaviour of beta2-microglobulin removal with different dialysis schedules.
    David S; Bottalico D; Tagliavini D; Mandolfo S; Scanziani R; Cambi V
    Nephrol Dial Transplant; 1998; 13 Suppl 6():49-54. PubMed ID: 9719205
    [No Abstract]   [Full Text] [Related]  

  • 2. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of acid-base control with different dialysis schedules.
    Feriani M
    Nephrol Dial Transplant; 1998; 13 Suppl 6():62-5. PubMed ID: 9719207
    [No Abstract]   [Full Text] [Related]  

  • 4. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hemofiltration in "poor risk" patients.
    Quellhorst EA; Schuenemann B; Mietzsch G
    ASAIO Trans; 1987; 33(3):758-64. PubMed ID: 3314940
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.
    Krieter DH; Lemke HD; Canaud B; Wanner C
    Biochim Biophys Acta; 2005 Nov; 1753(1):146-53. PubMed ID: 16154809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of serum beta-2 microglobulin using high-performance membranes and analysis of changes in serum BMG levels after dialysis.
    Yasuhiro I; Eiichi N; Mineo O; Muneto Y; Toshihiro I; Masahiro F; Yoshifumi N; Masahito M; Ryuichi M
    Am J Nephrol; 1998; 18(3):228-32. PubMed ID: 9627039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes.
    Krämer BK; Pickert A; Hohmann C; Liebich HM; Müller GA; Hablitzel M; Risler T
    Int J Artif Organs; 1992 Jul; 15(7):408-12. PubMed ID: 1516991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
    Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour of phosphate removal with different dialysis schedules.
    Messa P; Gropuzzo M; Cleva M; Boscutti G; Mioni G; Cruciatti A; Mazzolini S; Malisan MR
    Nephrol Dial Transplant; 1998; 13 Suppl 6():43-8. PubMed ID: 9719204
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes.
    Jørstad S; Smeby LC; Balstad T; Widerøe TE
    Blood Purif; 1988; 6(2):96-105. PubMed ID: 3293621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vicenza wearable artificial kidney for peritoneal dialysis (ViWAK PD).
    Ronco C; Fecondini L
    Blood Purif; 2007; 25(4):383-8. PubMed ID: 17785968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of beta 2-microglobulin in various types of hemodialysis].
    Hrvacević R; Veljancić Lj; Vujanić S; Radojević M; Aleksić S; Marić M
    Vojnosanit Pregl; 1999; 56(6):619-24. PubMed ID: 10707611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dialysis membrane on serum beta 2-microglobulin in chronic haemodialysis patients.
    Locatelli F; Di Filippo S; Manzoni C
    Nephrol Dial Transplant; 1997 Dec; 12(12):2804. PubMed ID: 9430911
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the beta 2-microglobulin level during hemodialysis].
    Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
    Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta 2 microglobulin amyloidosis and biocompatibility of the membranes used for extrarenal blood purification].
    Fardellone P; Delacroix C; Renaud H; Brasseur J; Marie A; Sebert JL; Fournier A
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):127-8. PubMed ID: 2657997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.